➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
Johnson and Johnson
AstraZeneca
McKinsey

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

Zogenix Inc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZOGENIX INC, and what generic alternatives to ZOGENIX INC drugs are available?

ZOGENIX INC has one approved drug.

There are ten US patents protecting ZOGENIX INC drugs.

There are forty-six patent family members on ZOGENIX INC drugs in twenty countries.

Summary for Zogenix Inc
International Patents:46
US Patents:10
Tradenames:1
Ingredients:1
NDAs:1
Drug Master File Entries: 1

Drugs and US Patents for Zogenix Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 9,549,909   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 10,603,290   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 9,603,815   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 10,478,441   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 9,610,260   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes   Get Started Free   Get Started Free
Zogenix Inc FINTEPLA fenfluramine hydrochloride SOLUTION;ORAL 212102-001 Jun 25, 2020 RX Yes Yes 10,947,183   Get Started Free Y Y   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Zogenix Inc Drugs

Country Patent Number Estimated Expiration
Japan 2020063309   Get Started Free
South Africa 201705078   Get Started Free
World Intellectual Property Organization (WIPO) 2014177676   Get Started Free
Mexico 2017004065   Get Started Free
Australia 2020202655   Get Started Free
New Zealand 730560   Get Started Free
Taiwan 201821071   Get Started Free
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Express Scripts
Baxter
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.